Pelvic exenteration and composite sacral resection in the surgical treatment of locally recurrent rectal cancer.

Background: The incidence of rectal cancer recurrence after surgery is 5-45%. Extended pelvic resection which entails En-bloc resection of the tumor and adjacent involved organs provides the only true possible curative option for patients with locally recurrent rectal cancer.

Aim: To evaluate the surgical and oncological outcome of such treatment.